Literature DB >> 12493354

Geriatric considerations in the diagnosis and management of overactive bladder.

Joseph G Ouslander1.   

Abstract

Numerous considerations affect the diagnosis and management of overactive bladder (OAB) in older patients, including neurologic and cardiovascular disorders, musculoskeletal conditions, diabetes, and psychiatric disorders. Older patients are commonly prescribed multiple medications, and many medications can contribute to OAB symptoms and/or interact with drug treatment for OAB. In addition to chronic illnesses and related medications, several factors outside the lower urinary tract can play an important part in managing OAB in older patients. These factors include mobility disorders, cognitive impairment, bowel habits, and fluid intake. Moreover, OAB often does not occur in isolation in the geriatric population. Estrogen deficiency and sphincter weakness in women, prostatic enlargement and obstruction in men, and impaired bladder contractility in both sexes are common and can have prominent effects on management. The diagnostic evaluation of geriatric patients with OAB can usually be accomplished with a basic assessment, without more invasive and expensive procedures. Treatment depends on numerous factors, ranging from comorbidities and functional status to transportation, finances, and patient and caregiver preferences. Adverse effects of bladder-relaxant medications can be bothersome and exacerbate existing conditions common in older patients (eg, constipation, glaucoma, gastroesophageal reflux, and dementia). Setting realistic goals for treatment and communicating them clearly to older patients and their caregivers are crucial for patient satisfaction. There are myriad opportunities for research designed to improve the management of OAB in the geriatric population.

Entities:  

Mesh:

Year:  2002        PMID: 12493354     DOI: 10.1016/s0090-4295(02)01795-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin.

Authors:  Linda Cardozo; David Castro-Diaz; Marc Gittelman; Arwin Ridder; Moses Huang
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-20

2.  [Diagnosis of overactive bladder (OAB)].

Authors:  M Kurosch; R Mager; K Gust; M Brandt; H Borgmann; A Haferkamp
Journal:  Urologe A       Date:  2015-03       Impact factor: 0.639

3.  [When is a urodynamic investigation indicated for overactive bladder?].

Authors:  S Schumacher
Journal:  Urologe A       Date:  2003-04-26       Impact factor: 0.639

4.  [Characteristics of urinary incontinence in the elderly].

Authors:  A Wiedemann; R Anding; R Kirschner-Hermanns
Journal:  Urologe A       Date:  2014-10       Impact factor: 0.639

Review 5.  Pharmacologic management of overactive bladder.

Authors:  Sum Lam; Olga Hilas
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

6.  Potential benefits of diagnosis and treatment on health outcomes among elderly people with symptoms of overactive bladder.

Authors:  L K Lee; A Goren; K H Zou; K Odell; D Russell; A L Araiza; X Luo
Journal:  Int J Clin Pract       Date:  2015-12-09       Impact factor: 2.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.